Lymphocytes T and B in rabbits infected with RHD virus

2013 ◽  
Vol 16 (3) ◽  
pp. 563-565
Author(s):  
P. Niedźwiedzka-Rystwej ◽  
B. Tokarz-Deptuła ◽  
W. Deptuła

Abstract The aim of this study was to determine the differences in immunological response of animals infected with different antigenic variants of the virus - three haemagglutinating (Vt97, Triptis, Hartmannsdorf) and two non-haemagglutinating (Pv97, 9905 RHDVa). The specific immunological response was measured by the dynamics of changes in the amount of lymphocytes T (with CD5+, CD4+, CD8+, CD25+ receptor) and B (with CD19+ receptor). The study showed differences in immunogenicity of the analysed RHDV antigenic variants, which allowed them to be divided into groups of: more immunogenic strains, including non-haemagglutinating 9905 RHDVa and haemagglutinating Vt97 and Triptis variants; and less immunogenic strains, including the haemagglutinating Hartmannsdorf variant and the non-haemagglutinating Pv97 variant. Such a result may indicate that the agglutination capacity of red blood cells might not be a factor impacting the number of T and B lymphocytes.

Vox Sanguinis ◽  
2004 ◽  
Vol 87 (1) ◽  
pp. 46-47 ◽  
Author(s):  
F. Callera ◽  
C. M. T. Pessoa de Melo ◽  
C. V. Rubens ◽  
A. M. M. P. Cavalcante ◽  
V. Buccheri

Author(s):  
Michel Leclerc

Next to the sea star T and B lymphocytes, we find the IPA (Invertebrate Primitive Antibody). Rosetting test and PFC test  after Injection of SRBC (Sheep red blood cells)were performed in the sea starAsterias rubens (Echinodermata). Positive results were obtained and summarized in this work. They indicated the presence of anti-SRBC antibodies in the sea star, according to the method of Cunningham.


1989 ◽  
Vol 88 (3) ◽  
pp. 312-316
Author(s):  
Carlo Garzelli ◽  
Antonio Marchetti ◽  
Anna Pacciardi ◽  
Carla Puglisi ◽  
Fulvio Basolo

1986 ◽  
Vol 14 (01n02) ◽  
pp. 33-36
Author(s):  
G.M. Sein ◽  
M. Phil

The effects of Korean herbal medicine (B.C.L.) on some parametrs of immunological response were studied in mice, B.C.L. pretreatment given either intraperitoneally subcutaneously in a dose of 0.75 mg/mouse did not significantly inhibit lymphocyte transformation induced by concanavalin A. However, B.C.L. pretreatment in a dose of 2.25 mg/mouse was found to reduce significantly both the plaque-forming cells to sheep red blood cells immunisation as well as total splee cell population. Thus, B.C.L. pretreatment with a higher does (2.25 mg/mouse) can selectively depress the humoral immune response. It is unclear, however, whether this action is mediated by the parent compound or its metabolities.


Author(s):  
Roger Ktavtzoff ◽  
Isabelle Desbois ◽  
Christian Doinel ◽  
Philippe Colombat ◽  
Jean Pierre Lamagnere ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document